Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Retina UK is a leading national charity in the United Kingdom dedicated to supporting people affected by inherited progressive sight loss and investing in medical research to find treatments. Founded in 1976, the organization funds cutting-edge research into the causes and potential cures for conditions such as retinitis pigmentosa, Usher syndrome, and Stargardt disease. Beyond research funding, Retina UK provides extensive support services, including a national helpline, local support groups, and educational resources for patients and healthcare professionals. The charity plays a pivotal role in the ophthalmic community by bridging the gap between patients and scientific advancements in gene and stem cell therapies. By collaborating with world-class academic institutions, Retina UK ensures that the patient voice is central to the development of future clinical trials and therapeutic interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Retina UK.